| Description | |||
| Tumor mutational burden (TMB) is the most promising genotyping biomarker for immuno-oncology (I-O) therapeutic response, but its clinical application depends on accurate, consistent measurement by targeted NGS panels.We are currently developing and delivering custom TMB reference standards. | |||
| Cat.No. | ID | TMB Value | Method |
| CBP80001-1 | tTMB-P1 | 5.37 | WES |
| CBP80001-2 | tTMB-P2 | 9.84 | WES |
| CBP80001-3 | tTMB-P3 | 12.41 | WES |
| CBP80001-4 | tTMB-P4 | 21.09 | WES |
| CBP80001-5 | tTMB-P5 | 27.15 | WES |
| CBP80001-6 | tTMB-P6 | 8.98 | WES |
| CBP80001-7 | tTMB-P7 | 6.83 | WES |
| CBP80001-8 | tTMB-P8 | 27.15 | WES |
| CBP80001-9 | tTMB-P9 | N/A | WES |
| CBP80001-10 | bTMB-P1 | 22.91 | WES |
| Detail for WES | |||
| Capture probe： | IDT xGenExome Research Panel v1.0 | ||
| Sequencer model： | HiSeq X-TEN | ||
| Sequencing depth： | 500x | ||
| Calculation： | Please contact us | ||
| Raw data download： | Please contact us | ||
E-mail：sales@reqbio.com
Add:3rd Floor, No. 6, Lane 222,
Guangdan Road, Pudong New Area,
Shanghai，China
WeChat public account
